 Home > Medical News > Medical World News > FDA approves upgraded version of Moderna, Pfizer vaccines for certain populations

FDA approves upgraded version of Moderna, Pfizer vaccines for certain populations

 Last Update: 2022-09-06
 Source: Internet
 Author: User

Tags

single use items

moderna cancer vaccine

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

The U.
S.
Food and Drug Administration on August 31 revised the emergency use authorization for Moderna and Pfizer’s new crown vaccines, approving certain age groups to receive upgraded versions of these two vaccines as booster shots to provide for the Omicron variant.
better protection
.
The U.
S.
Food and Drug Administration said in a statement that the upgraded vaccine is a bivalent vaccine that targets the original strain of the new coronavirus as well as the new subtypes BA.
4 and BA.
5 of the new coronavirus Omicron variant.
role
.
According to the FDA authorization, the public can receive the upgraded version of Moderna or Pfizer vaccine as a single booster dose at least two months after the completion of the initial vaccination or booster dose
.
The upgraded version of the Moderna vaccine is suitable for people 18 years of age and older, and the upgraded version of the Pfizer vaccine is suitable for people 12 years of age and older
.
The FDA said that the new subtypes BA.
4 and BA.
5 are currently the dominant strains in the United States, and the two new subtypes are expected to continue to spread this fall and winter
.
FDA Commissioner Robert Califf said in a statement that public indoor activity time will increase after entering the fall, and it is strongly recommended that eligible members of the public receive upgraded vaccines to better protect against currently circulating mutant strains
.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

High Quality Pharmaceutical Intermediate API Raw Material 3,4-difluoro- CAS 2396750-32-4

CAS No.: 2396750-32-4

Industrial Grade

$700.00/G EXW

9-[3-Chloro-5-(phenanthren-9-yl)phenyl]phenanthrene / 1369431-34-4

CAS No.: 1369431-34-4

Chemical Grade

$10/KG FOB

Molybdenum hexacarbonyl

CAS No.: 13939-06-5

$1/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.